温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.msd.com/research/
点击访问原文链接

Research - MSD

进入原网站 导航首页
CompanyWho we areWhat we doStoriesHistorySustainabilitySustainability overviewPhilanthropyMSD Medical Outreach ProgramImpact Venture FundTransparency disclosuresSustainability resourcesLeadershipLeadership overviewBoard of directorsExecutive teamCulture & valuesCulture & values overviewCode of conduct, ethics and complianceDiversity and inclusionPolicies and positionsSuppliersSuppliers overviewSupplier registrationSupplier help for AribaResearchResearch overviewOncologyVaccinesInfectious diseasesCardiometabolic and respiratory diseasesImmunologyNeuroscienceOphthalmologyAreas of innovationData science and artificial intelligenceGreen and sustainable scienceOur therapeutic modalitiesTranslational medicinePipelineBusiness development and licensingClinical TrialsClinical trials overviewDiversity in clinical trialsR&D locationsHow we inventMeet our scientistsPublicationsSafety data sheets (SDS)Product patentsPatientsPatients overviewPlay an active role in your health careFighting counterfeit medicineMediaMedia overviewNews releasesCompany statementsCompany fact sheetInvestorsInvestors overviewEvents and presentationsStock informationCareersLearn moreContact usCareersPipelinePublicationsLearn moreOur work in oncologyOur work in vaccinesOur work in infectious diseasesOur work in cardiometabolic and respiratory diseasesOur work in immunologyOur work in neuroscienceOur work in ophthalmologyData science and artificial intelligenceGreen and sustainable scienceOur therapeutic modalitiesTranslational medicineCheck out our pipelineCollaborate with usLearn about clinical trialsExplore our publicationsHow we inventMeet our scientistsDean LiEliav BarrGeorge AddonaLearn more about our programView all of our R&D locations.TL1A: Exploring a potentially important target for inflammatory bowel disease Our scientists are investigating ways to modulate TL1A to potentially address inflammation and fibrosis associated with inflammatory bowel diseaseWhat is One Pipeline? How we’re advancing the best internal and external science to progress our pipeline for patientsMeet two scientists at the forefront of our HIV research Two esteemed scientists share their motivations and hopes for the future of HIV researchExploring the potential use of PET tracers in neurodegenerative disease research MSD scientists are researching the potential of an investigational alpha-synuclein PET tracer in early identification of Parkinson’s diseaseExplore the possibilitiesPatients We're here to help you get the information you need to guide you on your health journey.Investors Find our latest financials, events & presentations, news, stock information, and contacts.Who we are We aspire to be the premier research-intensive biopharmaceutical company.MSD ManualsClinical trialsImpact ReportMSD for MothersMSD Animal HealthContact UsForward-looking statementCookie policyPrivacyTerms of useAccessibilitySitemapwww.sec.govDecline

智能索引记录